CH

Medela Ag


USPTO Granted Patents = 12

% Expired Patents = 8.3


Trademarks = 2

Forward Citations = 184

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Andy Greter (3 out of 36 patents)

silverMedal Sebastian Höner (3 out of 6 patents)

bronzeMedal Sandra Rückewold (2 out of 6 patents)

4.  Anita Treiber (2 out of 2 patents)

5.  Martin Thüring (1 out of 5 patents)

6.  Hilmar Ehlert (1 out of 12 patents)

7.  Brian H Silver (1 out of 71 patents)

8.  Richard Röllin (1 out of 7 patents)

9.  Markus Kerschdorfer (1 out of 3 patents)

10.  Yvonne Krebs (1 out of 3 patents)

11.  Hansruedi Kuenzler (1 out of 1 patent)

12.  Beda Weber (1 out of 1 patent)

13.  Michael N Larsson (1 out of 21 patents)

14.  Therese Naef (1 out of 47 patents)

15.  Thomas Imhof (1 out of 2 patents)


12 patents:

Company Overview
Medela AG is a Swiss company specializing in the development and manufacturing of medical devices and solutions, particularly in the fields of maternal and infant health. The organization is renowned for its innovative breast pump technology and products that support breastfeeding, as well as its contributions to healthcare solutions for hospitals and home care. Medela's commitment to research and development drives advancements in medical technology, enhancing the quality of care for mothers and infants globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#49 in

#928 in Switzerland

#48,163 in the World

CH
CH
Forward Citations = 184

27 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medela Ag. Retrieved from https://idiyas.com/company/medela-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…